Document is current
Any future updates will be listed below
-
Authors
Muhammad, Ayesha
Calandranis, Maria E.
Li, Bian
Yang, Tao
Blackwell, Daniel J.
Harvey, M. Lorena
Smith, Jeremy E.
Daniel, Zerubabell A.
Chew, Ashli E.
Capra, John A.
Matreyek, Kenneth A.
Fowler, Douglas M.
Roden, Dan M.
Glazer, Andrew M. http://orcid.org/0000-0002-3938-4713
-
Funding
Funding for this research was provided by:
National Human Genome Research Institute (R00 HG010904, RM1 HG010461)
National Heart, Lung, and Blood Institute (R01 HL149826, R01 HL164675)
American Heart Association (20PRE35180088)
National Institute of General Medical Sciences (T32GM007347, R35GM150465)
National Cancer Institute (P30 CA68485)
National Institute of Diabetes and Digestive and Kidney Diseases (DK058404)
- License Information
-
More Information
Article History
Received: 28 June 2023
Accepted: 26 April 2024
First Online: 30 May 2024
Declarations
:
: This study was determined to constitute non-human subject research based on the Helsinki Declaration. All patient data used were obtained from publicly available datasets (gnomAD, ClinVar, and literature reports). No new human data were generated during this study.
: Not applicable.
: AMG is a consultant for BioMarin, Inc. BL is now a paid employee of Regeneron Pharmaceuticals, Inc. The remaining authors declare that they have no competing interests.
